BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20226877)

  • 1. Alterations of cholesterol precursor levels in Alzheimer's disease.
    Kölsch H; Heun R; Jessen F; Popp J; Hentschel F; Maier W; Lütjohann D
    Biochim Biophys Acta; 2010 Aug; 1801(8):945-50. PubMed ID: 20226877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease.
    Popp J; Meichsner S; Kölsch H; Lewczuk P; Maier W; Kornhuber J; Jessen F; Lütjohann D
    Biochem Pharmacol; 2013 Jul; 86(1):37-42. PubMed ID: 23291240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
    Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
    Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
    Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
    Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism.
    Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Friedrichs S; Maier TA; Heun R
    J Cell Mol Med; 2009 Mar; 13(3):589-98. PubMed ID: 19374686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
    Lütjohann D; von Bergmann K
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease.
    Kölsch H; Lütjohann D; Jessen F; Von Bergmann K; Schmitz S; Urbach H; Maier W; Heun R
    Int J Mol Med; 2006 May; 17(5):791-4. PubMed ID: 16596262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol.
    Baila-Rueda L; Mateo-Gallego R; Jarauta E; de Castro-Orós I; Bea AM; Cenarro A; Civeira F
    Biochem Biophys Res Commun; 2014 Apr; 446(3):731-5. PubMed ID: 24406166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
    J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
    Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
    Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
    Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
    Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms.
    Besga A; Cedazo-Minguez A; Kåreholt I; Solomon A; Björkhem I; Winblad B; Leoni V; Hooshmand B; Spulber G; Gonzalez-Pinto A; Kivipelto M; Wahlund LO
    Neurosci Lett; 2012 Feb; 510(2):121-6. PubMed ID: 22281444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
    Sauder S; Kölsch H; Lütjohann D; Schulz A; von Bergmann K; Maier W; Heun R
    J Neural Transm (Vienna); 2005 Oct; 112(10):1381-9. PubMed ID: 15666037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum noncholesterol sterols in Alzheimer's disease: the Helsinki Businessmen Study.
    Sittiwet C; Simonen P; Nissinen MJ; Gylling H; Strandberg TE
    Transl Res; 2018 Dec; 202():120-128. PubMed ID: 30102918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
    Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
    J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease.
    Popp J; Lewczuk P; Kölsch H; Meichsner S; Maier W; Kornhuber J; Jessen F; Lütjohann D
    J Neurochem; 2012 Oct; 123(2):310-6. PubMed ID: 22845771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
    Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
    Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease.
    Kölsch H; Lütjohann D; Jessen F; Urbach H; von Bergmann K; Maier W; Heun R
    J Neural Transm (Vienna); 2006 Feb; 113(2):231-8. PubMed ID: 15959845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
    Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
    Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.